Atorvastatin for acute coronary syndromes
- PMID: 11476650
Atorvastatin for acute coronary syndromes
Comment on
-
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.JAMA. 2001 Apr 4;285(13):1711-8. doi: 10.1001/jama.285.13.1711. JAMA. 2001. PMID: 11277825 Clinical Trial.
-
Lipid-lowering therapy in acute coronary syndromes.JAMA. 2001 Apr 4;285(13):1758-60. doi: 10.1001/jama.285.13.1758. JAMA. 2001. PMID: 11277832 No abstract available.
-
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).JAMA. 2001 May 16;285(19):2486-97. doi: 10.1001/jama.285.19.2486. JAMA. 2001. PMID: 11368702 No abstract available.
Similar articles
-
Atorvastatin for acute coronary syndromes.JAMA. 2001 Aug 1;286(5):532-3; author reply 533-5. doi: 10.1001/jama.286.5.532. JAMA. 2001. PMID: 11476649 No abstract available.
-
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease.N Engl J Med. 1999 Dec 9;341(24):1854-5. N Engl J Med. 1999. PMID: 10610466 No abstract available.
-
Statin therapy and the elderly: SAGE advice?Circulation. 2007 Feb 13;115(6):681-3. doi: 10.1161/CIRCULATIONAHA.106.678300. Circulation. 2007. PMID: 17296867 No abstract available.
-
[AVERT [The Atorvastatin versus Revascularization Treatment]].Nihon Rinsho. 2001 Mar;59 Suppl 3:436-41. Nihon Rinsho. 2001. PMID: 11347110 Review. Japanese. No abstract available.
-
[Atorvastatin].Nihon Rinsho. 2001 Mar;59 Suppl 3:598-604. Nihon Rinsho. 2001. PMID: 11347138 Review. Japanese. No abstract available.
Cited by
-
Differential Benefit of Statin in Secondary Prevention of Acute Myocardial Infarction according to the Level of Triglyceride and High Density Lipoprotein Cholesterol.Korean Circ J. 2016 May;46(3):324-34. doi: 10.4070/kcj.2016.46.3.324. Epub 2016 May 27. Korean Circ J. 2016. PMID: 27275169 Free PMC article.
-
Generating Practice-Based Evidence in the Use of Guideline-Recommended Combination Therapy for Secondary Prevention of Acute Myocardial Infarction.Pharmacy (Basel). 2022 Nov 3;10(6):147. doi: 10.3390/pharmacy10060147. Pharmacy (Basel). 2022. PMID: 36412823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical